Nisa Investment Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $149K | Buy |
8,620
+1,817
| +27% | +$24.9K | ﹤0.01% | 1359 |
|
|
2026
Q1 | $84.6K | Buy |
6,803
+264
| +4% | +$3.54K | ﹤0.01% | 1489 |
|
|
2025
Q4 | $82.4K | Sell |
6,539
-400
| -6% | -$4.58K | ﹤0.01% | 1491 |
|
|
2025
Q3 | $69.5K | Hold |
6,939
| – | – | ﹤0.01% | 1537 |
|
|
2025
Q2 | $56.1K | Sell |
6,939
-357
| -5% | -$2.69K | ﹤0.01% | 1558 |
|
|
2025
Q1 | $61.1K | Buy |
7,296
+39
| +0.5% | +$326 | ﹤0.01% | 1544 |
|
|
2024
Q4 | $57.5K | Buy |
7,257
+188
| +3% | +$1.58K | ﹤0.01% | 1647 |
|
|
2024
Q3 | $58.8K | Sell |
7,069
-221,848
| -97% | -$1.73M | ﹤0.01% | 1604 |
|
|
2024
Q2 | $1.45M | Buy |
228,917
+222,144
| +3,280% | +$1.41M | 0.01% | 780 |
|
|
2024
Q1 | $41K | Buy |
6,773
+73
| +1% | +$412 | ﹤0.01% | 1703 |
|
|
2023
Q4 | $40.7K | Hold |
6,700
| – | – | ﹤0.01% | 1687 |
|
|
2023
Q3 | $28.3K | Hold |
6,700
| – | – | ﹤0.01% | 1903 |
|
|
2023
Q2 | $20.8K | Buy |
6,700
+5,180
| +341% | +$11K | ﹤0.01% | 2089 |
|
|
2023
Q1 | $2K | Hold |
1,520
| – | – | ﹤0.01% | 2310 |
|
|
2022
Q4 | $3K | Hold |
1,520
| – | – | ﹤0.01% | 2326 |
|
|
2022
Q3 | $3K | Hold |
1,520
| – | – | ﹤0.01% | 2332 |
|
|
2022
Q2 | $5K | Hold |
1,520
| – | – | ﹤0.01% | 2265 |
|
|
2022
Q1 | $6K | Sell |
1,520
-630
| -29% | -$2.79K | ﹤0.01% | 2275 |
|
|
2021
Q4 | $10K | Hold |
2,150
| – | – | ﹤0.01% | 2025 |
|
|
2021
Q3 | $11K | Hold |
2,150
| – | – | ﹤0.01% | 2190 |
|
|
2021
Q2 | $11K | Sell |
2,150
-17,900
| -89% | -$102K | ﹤0.01% | 2213 |
|
|
2021
Q1 | $135K | Hold |
20,050
| – | – | ﹤0.01% | 1625 |
|
|
2020
Q4 | $92K | Buy |
20,050
+1,150
| +6% | +$5.1K | ﹤0.01% | 1766 |
|
|
2020
Q3 | $73K | Hold |
18,900
| – | – | ﹤0.01% | 1649 |
|
|
2020
Q2 | $90K | Sell |
18,900
-11,800
| -38% | -$48.6K | ﹤0.01% | 1466 |
|
|
2020
Q1 | $107K | Buy |
30,700
+30,375
| +9,346% | +$129K | ﹤0.01% | 1351 |
|
|
2019
Q4 | $2K | Sell |
325
-39,120
| -99% | -$136K | ﹤0.01% | 1987 |
|
|
2019
Q3 | $114K | Buy |
39,445
+39,120
| +12,037% | +$136K | ﹤0.01% | 1431 |
|
|
2019
Q2 | $2K | Hold |
325
| – | – | ﹤0.01% | 1971 |
|
|
2019
Q1 | $5K | Sell |
325
-15,382
| -98% | -$203K | ﹤0.01% | 1897 |
|
|
2018
Q4 | $213K | Hold |
15,707
| – | – | ﹤0.01% | 1225 |
|
|
2018
Q3 | $349K | Buy |
15,707
+15,382
| +4,733% | +$324K | ﹤0.01% | 1196 |
|
|
2018
Q2 | $5K | Buy |
+325
| New | +$5.7K | ﹤0.01% | 1829 |
|
Other funds holding AMRX
TGA
RCMNY
Nisa Investment Advisors's AMRX Position: Q2 2026 in Review
Nisa Investment Advisors increased its Amneal Pharmaceuticals (AMRX) stake by 27% in Q2 2026, buying an estimated $24.9K and bringing the position to 8,620 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1359.
Nisa Investment Advisors first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.45M in Q2 2024. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Nisa Investment Advisors held 8,620 shares of Amneal Pharmaceuticals worth $149K as of Q2 2026.
- Nisa Investment Advisors bought 1,817 Amneal Pharmaceuticals shares in Q2 2026, an estimated $24.9K.
- Amneal Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1359 holding.
- Nisa Investment Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- Nisa Investment Advisors's Amneal Pharmaceuticals position peaked at $1.45M in Q2 2024.
- 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.